NEU 2.99% $20.10 neuren pharmaceuticals limited

Ann: Investor presentation, 8 November 2023, page-2

  1. 1,386 Posts.
    lightbulb Created with Sketch. 284
    As Trofinetide and NNZ2591 are understood to have different mechanisms of action, has Neuren ever trialed both drugs together in mice?
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.